Algorae Pharmaceuticals Limited
1AI
株式のランク
#30811
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
株価
$0.00702515
時価総額
$14.24M
変化（1日）
0.00%
変化（1年）
-30.99%
国
AU
取引 Algorae Pharmaceuticals Limited (1AI)
カテゴリー
Healthcare
Algorae Pharmaceuticals Limited（1AI）の株価履歴
終値の最高値: $0.01 （2023-10-01）
終値の最安値: $0.18 （2004-08-01）
終値の最安値: $0.18 （2004-08-01）
Algorae Pharmaceuticals Limited の株価履歴（2004 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2023 | 6.81% |
| 2022 | 127.17% |
| 2021 | -62.32% |
| 2020 | -1.87% |
| 2019 | -62.42% |
| 2018 | 44.81% |
| 2017 | -68.09% |
| 2016 | 92.42% |
| 2015 | -37.24% |
| 2014 | -34.11% |
| 2013 | 61.27% |
| 2012 | 1.22% |
| 2011 | -64.54% |
| 2010 | -38.56% |
| 2009 | 207.71% |
| 2008 | -77.10% |
| 2007 | 101.95% |
| 2006 | -3.09% |
| 2005 | -54.59% |
| 2004 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $536.73 | 25.86% |
US
|
|
| $225.94 | 741.49% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $878.85 | 7.94% |
NL
|
